Capitolis Advisors LLC Bristol Myers Squibb CO Transaction History

Capitolis Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $11.2 Million - $13.4 Million	-181,600 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $1.51 Million - $1.76 Million	28,097 Added 18.3%	181,600 $11.3 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $17 Million - $18.5 Million	-274,433 Reduced 64.13%	153,503 $10.3 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $8.49 Million - $9.55 Million	143,118 Added 50.25%	427,936 $27 Million
Q4 2020 May 07, 2021	BUY	$57.74 - $65.43 $16.4 Million - $18.6 Million	284,818 New	284,818 $17.7 Million

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $114B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Capitolis Advisors LLC with notifications on news.